Skip to main content
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
You are here
Home
News by month %2 2013
News by month December 2013
PTCommunity News December 2013
Top 10 U.S. Well-Being Discoveries in 2013
New Drug Application Submitted for Once-Daily Tacrolimus (Envarsus) in Kidney Transplant Recipients
Report: African-American Women Have Higher Rates of Hypertension
Breast Cancer Treatments Show Promise in Mid-Stage Trial
Investigational Lung Cancer Drug Disappoints in Phase II Study
FDA Agrees to Review New Insulin Glargine Product
Study: Infectious Diarrhea Germs Stick to Health Care Workers’ Hands
Liraglutide Submitted for Regulatory Approval as Obesity Treatment
FDA Delays Decision on Expanded Labeling for Vascepa (Icosapent Ethyl)
Cancer Immunotherapy Named ‘Breakthrough of the Year’
Report: New Oral Anticoagulants Will Drive Growth in Atrial Fibrillation Drug Market
Positive Results Reported for Sofosbuvir/Ledipasvir in Hepatitis Patients
Dabigatran (Pradaxa) Superior to Warfarin in Patients With Thrombosis or Embolism
FDA Approves Anoro Ellipta (Umeclidinium/Vilanterol) to Treat COPD
Positive Phase II Results Reported for Brain Cancer Vaccine
NCI Report: Lung Cancer Death Rates Continue to Fall
Positive Phase III Results Reported for Evolocumab in Patients With High Cholesterol
Medicare Identifies Best And Worst Hospitals For Hip And Knee Replacements
FDA Approves First Device to Relieve Migraine Pain
Medications Developed for Other Uses May Curb Cervical Cancer
FDA Issues Proposed Rule for Antibacterial Soaps
Positive Results Reported for Ceftolozane/Tazobactam in Intra-Abdominal Infections
Analysts See Chronic-Pain Drug Market Rebounding From Generic Erosion Over Next Decade
FDA Advisors Recommend Approval of Dapagliflozin for Type 2 Diabetes
Study: U.S. Ranks Near Bottom in Efficiency of Health Care Spending
Positive Results Reported for Gout Therapy Lesinurad in Phase III Trial
Study: Stomach Acid Drugs May Increase Risk of Vitamin B<sub>12</sub> Deficiency
FDA Advisors Recommend Approval of Bowel Disease Drug Vedolizumab
FDA Approves Sofosbuvir (Sovaldi) for Treatment of Chronic Hepatitis C
Diabetes Identified as Risk Factor for Liver Cancer Across Ethnic Groups
CDC Report: Measles Still a Threat
FDA Advisors See PML Risk With Colitis Drug Vedolizumab
Combo Asthma Drug Improves Lung Function in Phase III Study
Swallowing a Diagnostic Pill
Depression Drug Fails Late-Stage Trials
FDA Issues Safety Communication on Defibrillators
Report: Sales of Antiretroviral Drugs for HIV Will Decrease Slightly Over Next Decade
Hematology Society Releases List of Questionable Tests and Treatments
FDA to Review Zalviso (Sublingual Sufentanil) for Treatment of Acute Pain
Gallup Poll: Americans’ Desire to Shed Pounds Outweighs Effort
Biologics License Application Submitted for Fluarix
